Individuals who may warrant closer monitoring include: Those with a personal or family history of depression , anxiety, or other mood disorders People who have previously experienced mood changes on other weight-loss medications or GLP-1-based therapies Individuals with eating disorders or a complex relationship with food , for whom appetite suppression may have psychological implications (see NICE guideline NG69: Eating disorders: recognition and treatment) [10] Those experiencing significant life stressors alongside starting a new treatment People with poorly controlled type 2 diabetes , where fluctuating blood glucose levels both hypoglycaemia and hyperglycaemia can independently affect mood, concentration, and emotional wellbeing It is also worth acknowledging that obesity itself is associated with higher rates of depression and anxiety, and that the psychological experience of rapid body weight change whether positive or negative can be emotionally complex
GLP-1 medications have been around for a while for managing diabetes and some other conditions, and now theyre being used to help people lose weight
[] Because conventional pharmacotherapies for OCD include drugs that influence the 5-hydroxytryptamine (5-HT) and dopamine systems but have poor clinical efficacy, recent targeted clinical and preclinical investigations are concentrating on glutamate-modulating medicines in OCD patients
Inflamm Bowel Dis (2017) 23:213
12), Monster Energy Blend: Taurine, L-Carnitine, Caffeine, Inositol Product Detail Some people are impossible to please
